Article
Chicago - Outpatient, self-administered chemobiotherapy can be delivered safely and effectively for patients with metastatic melanoma, according to a study presented at the 39th annual meeting of the American Association of Clinical Oncology.
Innovating Scalp Care: How Research and Education Drive Solutions
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Role of Zinc, Copper, and Vitamin D in Alopecia Areata Explored
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
QRX003 Shows Promise in Pediatric Patients with Netherton Syndrome, Quoin Announces
High-Risk CSCC Trial Validates Cemiplimab's Potential